Sorafenib inhibits growth and metastasis of hepatocellular carcinoma by blocking STAT3

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 34

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

581

HTML

7086

Figures (1-4)

298

Tables (1-1)

199

Sum=8164

Sep 14, 2011 (publication date) through Nov 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Sep 14, 2011; 17(34): 3922-3932
Published online Sep 14, 2011. doi: 10.3748/wjg.v17.i34.3922

Table 1 Sorafenib suppresses tumor growth and metastasis in vivo n (%)

^aP < 0.001, Student t test (vs vehicle group);

^bP < 0.05, Fisher’s exact test (vs vehicle group);

^cP < 0.05, Fisher’s exact test (vs vehicle group).

Citation: Gu FM, Li QL, Gao Q, Jiang JH, Huang XY, Pan JF, Fan J, Zhou J. Sorafenib inhibits growth and metastasis of hepatocellular carcinoma by blocking STAT3. World J Gastroenterol 2011; 17(34): 3922-3932
URL: https://www.wjgnet.com/1007-9327/full/v17/i34/3922.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i34.3922